创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

束庆, 范晴晴, 刘蕴星, 王丹丹, 孙凌云. 间充质干细胞移植在治疗自身免疫性疾病中的应用进展[J]. 药学进展, 2019, 43(4): 276-281.
引用本文: 束庆, 范晴晴, 刘蕴星, 王丹丹, 孙凌云. 间充质干细胞移植在治疗自身免疫性疾病中的应用进展[J]. 药学进展, 2019, 43(4): 276-281.
SHU Qing, FAN Qingqing, LIU Yunxing, WANG Dandan, SUN Lingyun. Progress in the Application of Mesenchymal Stem Cell Transplantation in Autoimmune Diseases[J]. Progress in Pharmaceutical Sciences, 2019, 43(4): 276-281.
Citation: SHU Qing, FAN Qingqing, LIU Yunxing, WANG Dandan, SUN Lingyun. Progress in the Application of Mesenchymal Stem Cell Transplantation in Autoimmune Diseases[J]. Progress in Pharmaceutical Sciences, 2019, 43(4): 276-281.

间充质干细胞移植在治疗自身免疫性疾病中的应用进展

Progress in the Application of Mesenchymal Stem Cell Transplantation in Autoimmune Diseases

  • 摘要: 自身免疫性疾病发病机制复杂,传统治疗方法对难治性自身免疫性疾病治疗效果有限,难以得到满意的结果。间充质干细胞因具有强大的免疫调节功能,已被应用于自身免疫性疾病、移植物抗宿主病、糖尿病等疾病的治疗。综述间充质干细胞发挥免疫调节的机制、间充质干细胞移植临床前研究以及在治疗自身免疫性疾病方面的临床应用进展。

     

    Abstract: The pathogenesis of autoimmune diseases is complex, and the therapeutic effects of traditional treatments on refractory autoimmune diseases are limited and unsatisfactory. Mesenchymal stem cells have been used in the treatment of diseases such as autoimmune diseases, graft-versus-host diseases and diabetes due to their strong immunomodulatory properties. This review summarizes the progress in the immunomodulatory mechanisms of mesenchymal stem cells, the pre-clinical study of mesenchymal stem cell transplantation and its clinical application in the treament of autoimmune diseases.

     

/

返回文章
返回